Crowell builds London tech practice with Baker Botts dealmaker

A general view is seen of the London skyline from Canary Wharf in London, Britain, October 19, 2016. REUTERS/Hannah McKay

Register now for FREE unlimited access to
  • David Ramm focuses on technology transactions and has advised on COVID-19 vaccine-related matters
  • Crowell & Moring has recently added several London lawyers

(Reuters) – Crowell & Moring said Thursday it has added David Ramm, who has advised technology companies and COVID-19 vaccine developers, as a partner on its London M&A team.

Ramm said he worked with UK-based biomedical company ViraCorp on the IP licensing, financing, manufacturing and distribution of a nasal COVID-19 vaccine which can be administered without a needle.

Ramm has also has advised vaccine manufacturer The Serum Institute of India Pvt Ltd on its investment in U.S. vaccine developer Codagenix Inc, he said.

Register now for FREE unlimited access to

Washington, D.C.-founded Crowell has grown in London, adding a four-laywer group of derivatives lawyers from McGuireWoods in December and other London lawyers earlier in 2021 through a merger with Wall Street law firm Kibbe & Orbe.

Ramm’s hire will deepen the firm’s ability to reach tech clients in London, according to a statement from Jennifer Grady, co-chair of Crowell’s corporate practice.

Data from Refinitiv for the first quarter of 2022 showed the technology sector consolidated its position as the busiest global M&A segment, with $258.9 billion in tech deals comprising a record 25% of global M&A volume.

Ramm’s technology clients have included Citibank, financial technology company Glint Pay Ltd and the Kingdom of Saudi Arabia’s new digital bank D360, according to an archived bio on Baker Botts’ website.

A spokesperson for Baker Botts said the firm wishes Ramm well.

Read more:

Cooley recruits M&A partner from Gibson Dunn in New York

Hogan Lovells lures Foley Hoag M&A co-leader in Boston

Freshfields recruits deal lawyer from Wilson Sonsini in Silicon Valley

Register now for FREE unlimited access to

Our Standards: The Thomson Reuters Trust Principles.

Read More

Dion Center